Article

September Social Media Round-Up—DEI, CMO, and Rocky Mount Resumes

This September, Albert Bourla, Pfizer’s CEO, attended Black Corporate Directors Conference to discuss minority representation across all sectors, and our social roundup starts with his thoughts on their mission. Our Chief Marketing Officer discusses his first year as Pfizer’s first CMO and where we go from here. It’s an illuminating read from an innovative thinker. In other news, we made a TIME Magazine list, announced a new plan to make sure clinical trials participants have access to their...

Meet 6 of the 20 Organizations Making an Impact Through the Global Health Innovation Grants Program

Since 2016, The Pfizer Foundation’s* Global Health Innovation Grants (GHIG) program has supported community-based initiatives that aim to improve quality of care and strengthen health systems in lower income countries. Now in its seventh year, 20 new recipients of the one-year grant program have each received US $100,000 to drive innovative solutions that help address vaccine-preventable illness in their communities."We launched the GHIG program rooted in the premise that local problems require...

Pfizer’s Rocky Mount Facility Restarts Production Amid First Phase of Post-Tornado Recovery Efforts

NEW YORK, September 25, 2023 – Pfizer Inc. (NYSE: PFE) has restarted the majority of its manufacturing lines at the Rocky Mount, North Carolina facility following severe damage from a tornado that hit the site on July 19. The resumption of production also includes the launch of one line in the site’s new sterile injectable manufacturing area referred to as R3, a state-of the-art module approved earlier this year by the U.S. Food and Drug Administration (FDA). This expedited restart is a proud...

Living & Wellbeing

Adolescents with Alopecia Areata: What Caregivers Should Know

A lot of kids just want to fit in.1 But for too many, hair loss makes them stand out. For the one in 1,000 children and teens diagnosed with alopecia areata (AA), an autoimmune disease that causes the immune system to attack the hair follicles, hair loss can create practical challenges.2,3Youth with AA might feel too self-conscious for selfies, refuse to go out without a hat, or decline invitations to swimming parties or sports leagues for fear their wigs will fall off. In a 2017 study of 69...

Patient-Friendly Health Literacy Resources for Cancer Patients and Caregivers

Being diagnosed with cancer can be overwhelming for anyone due to the emotional impact, level of uncertainty, and potential lifestyle changes. The challenges of accessing and understanding medical information introduce additional layers of complexity when patients navigate their care. Disparities and inequities can further restrict an individual’s capacity to develop the skills they need to look after their health.It is not enough for Pfizer to simply develop breakthrough medicines. We must help...

This Season’s COVID-19 Vaccine Rolls Outs Across U.S.

Our 2023-2024 COVID-19 vaccines are now available in pharmacies, hospitals, and clinics across the U.S., following a recommendation by The Centers for Disease Control and Prevention (CDC). Most Americans should continue to pay nothing out-of-pocket for this season’s vaccine, with costs covered through their health insurance or, at participating locations, through government programs for eligible uninsured and underinsured people.  Although COVID-19 circulates year-round, cases began climbing...

Advancing Metabolic Research in NASH, Obesity, and Cachexia Through Pfizer’s ASPIRE Program

Did you know that certain metabolic diseases are connected to one another by underlying biological factors? Non-alcoholic steatohepatitis (NASH), obesity, and cachexia are directly linked with heart health, and together they constitute a global public health concern that risks reaching epidemic proportions.     Pfizer is working to discover new medicines to help solve the significant patient needs associated with these conditions, but we recognize that no one company will be able to...

Trusted Voices

Bringing Together Diverse Organizations to Strive for Health Equity

As a Black woman who grew up living in subsidized housing in the U.S., I know what it means to live in a world where healthcare is not equal, and not trusted. Like so many others, I have family and friends along the health spectrum who have little interest in going to the doctor because they don’t feel seen or heard. This well-earned lack of trust has led some to decide against receiving the COVID-19 vaccine, among other healthcare services and interventions.  I know firsthand the work that...

Purpose & Ideals

Migraine in the Workplace and Creating a Safe Space

One billion people worldwide live with migraine; that’s about one in seven. At those odds, there’s a high probability that each of us works with someone who experiences migraine. And if you’re an employer, this could mean that migraine in the workplace could have a significant impact on your workforce.Migraine is a debilitating neurological disease that causes intense pain in the head, as well as other sensory and/or motor dysfunction. Migraine attacks usually include symptoms like nausea...

August Social Media Round-Up—Financial Update, World Humanitarian Day, RSV Vaccine

August typically brings two things: the dog days of summer and a lot of vacations! Social media tends to be a little quieter than usual, but that doesn’t mean there wasn’t plenty of activity on the Pfizer side of things. Our CEO provided a financial update, we celebrated World Humanitarian Day, and approvals for a pair of important vaccines. Catch up below. FROM OUR LEADERSHIP CEO Albert Bourla provides an update on Pfizer’s financial performance in the 2nd quarter: https://www.linkedin.com...

Behind the Migraine: Pfizer Colleagues Share Their Stories

We’ve all heard it before: “Migraine is more than just a headache.” But is it really understood? Some talk about the burden of migraine—the blur of pain, vice-like pressure, nausea, insomnia, and even vertigo—but most don’t. Migraine is a disabling neurological disease with different symptoms and treatment approaches compared to other headache disorders. An estimated 40 million people in the United States and more than 1 billion people around the world experience migraine attacks.1,2 So, at...

Race Against Resistance: Pfizer takes on AMR

A new film produced for Pfizer by BBC StoryWorks Commercial Productions puts the spotlight on the threat of antimicrobial resistance (AMR), a health crisis with global, and personal, impact. "Race Against Resistance” explores how the rise of antibiotic resistance, the process by which bacteria adapt and mutate to avoid the very drugs designed to kill them, is threatening to undo almost 100 years of progress in medicine.  “Race Against Resistance” shows what’s being done to tackle this global...